Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006227
Filing Date
2017-08-08
Accepted
2017-08-08 12:11:00
Documents
76
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prah-20170630x10q.htm 10-Q 1536107
2 EX-31.1 prah-20170630ex311af6a94.htm EX-31.1 18334
3 EX-31.2 prah-20170630ex3124d44d7.htm EX-31.2 18298
4 EX-32.1 prah-20170630ex321e3ae45.htm EX-32.1 8002
5 EX-32.2 prah-20170630ex322421e63.htm EX-32.2 7482
  Complete submission text file 0001558370-17-006227.txt   7218918

Data Files

Seq Description Document Type Size
6 EX-101.INS prah-20170630.xml EX-101.INS 1592387
7 EX-101.SCH prah-20170630.xsd EX-101.SCH 51954
8 EX-101.CAL prah-20170630_cal.xml EX-101.CAL 84174
9 EX-101.DEF prah-20170630_def.xml EX-101.DEF 223772
10 EX-101.LAB prah-20170630_lab.xml EX-101.LAB 562027
11 EX-101.PRE prah-20170630_pre.xml EX-101.PRE 409985
Mailing Address 4130 PARKLAKE AVENUE SUITE 400 RALEIGH NC 27612
Business Address 4130 PARKLAKE AVENUE SUITE 400 RALEIGH NC 27612 9197868200
PRA Health Sciences, Inc. (Filer) CIK: 0001613859 (see all company filings)

EIN.: 463640387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36732 | Film No.: 171013882
SIC: 8731 Services-Commercial Physical & Biological Research